=searchcontent_th~5^10000&ps=2&mm=100&qf=title_th_default&fq=system_name%3A%22Laws%20%2F%20Regulations%22&start=0&rows=10 1 - 5 of 5 results Sort by: Relevance Date (Newest) Date (Oldest) Notification of the
^10000&ps=2&mm=100&qf=title_th_default&fq=system_name%3A%22Laws%20%2F%20Regulations%22&start=0&rows=10 1 - 5 of 5 results Sort by: Relevance Date (Newest) Date (Oldest) Notification of the Securities and
determination of characteristics of bills deemed as securities. PP10 is therefore beyond the scope of the SEC’s supervision; 2. Further clarifying the description in the notification by 1) determining that
its overseas subsidiaries’ operation as well as continuing marketing and managing expense to support existing customers despite of reduced in sales growth as compared. 4. Financial Cost For the third
subsidiaries as well as marketing and managing expense to support existing customers. 4. Financial Cost For the second quarter of year 2018, the company had financial cost of Bt. 182.78 million which increased
including non-communicable diseases such cardiovascular disease, neurologic diseases, emergency care etc. Cost of Hospital Operations The cost of hospital operations for the 1st quarter of Year 2017 and 2018
increased 5.31% as a result of an increase in sales volume of sauces and condiments. Revenue from sale of goods 254.87 268.16 5.21% Cost of sale of goods (185.43) (172.39) -7.03% Gross profit 69.44 95.77
also increased by 2 0 .8 %. The number of both in-patient and out-paient were increased by 16.3%, also, revenue from out- patient and in-patient were increased by 14.7% and 31.5%. Cost of medical
itself and its overseas subsidiaries as well as marketing and managing expense to support existing customers. 4. Financial Cost For the year 2019, the company had financial cost of USD 29.27 million (or